R. A. RITTGERS, M.D.; M. S. LOEWENSTEIN, M.D.; A. E. FEINERMAN, M.D.; H. Z. KUPCHIK, Ph.D.; B. R. MARCEL, M.D.; R. S. KOFF, M.D., F.A.C.P.; N. ZAMCHECK, M.D.
One hundred ninety-one unselected fluid specimens submitted routinely for cytologic examination were assayed to determine whether the measurement of carcinoembryonic antigen (CEA) levels in pleural effusions is useful in detecting malignancy. The mean ± SD CEA level of 103 benign effusions was 4.1 ± 2.9 ng/ml. Only one benign effusion had a level > 12 ng/ml (18 ng/ml). Benign inflammatory effusions (pneumonia, empyema) had a higher mean CEA activity (6.2 ± 3.4) than effusions caused by congestive heart failure (2.9 ± 1.5) (p < 0.001). Twenty-four (34%) of 70 malignant effusions had a CEA level greater than 12 ng/ml, and 28 (40%) were "positive" by cytologic study. Thirty-eight (54%) were detected by one or both methods. Ten malignant effusions were positive by CEA (> 12 ng/ml) alone. These data suggest that the determination of CEA activity levels, when used in conjunction with other clinical findings, may be useful in detecting malignant pleural effusions.
RITTGERS RA, LOEWENSTEIN MS, FEINERMAN AE, et al. Carcinoembryonic Antigen Levels in Benign and Malignant Pleural Effusions. Ann Intern Med. 1978;88:631–634. doi: https://doi.org/10.7326/0003-4819-88-5-631
Download citation file:
Published: Ann Intern Med. 1978;88(5):631-634.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use